There are a myriad of surgical therapies for patients with end-stage congestive heart failure. Coronary revascularization and mitral valve repair have clear clinical benefits in appropriately selected patients. Further investigation is required before the widespread adoption of volume-reduction strategies. Cardiac stem cell therapies have yielded promising results in preclinical and phase I studies.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/j.semtcvs.2013.07.004 | DOI Listing |
Publication Analysis
Top Keywords
heart failure
8
current readings
4
readings surgical
4
surgical management
4
management heart
4
failure myriad
4
myriad surgical
4
surgical therapies
4
therapies patients
4
patients end-stage
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!